Clinical trial
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00029289 |
|---|---|
| Title | Effects of Lutein in Retinitis Pigmentosa |
| Official title | Effects of Lutein in Retinitis Pigmentosa |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Drug |
| Interventions | Lutein (10 or 30 mg/day) capsules |
| Start date | Apr 1, 2001 |
| Completion | Oct 1, 2002 |
| First posted | Jan 10, 2002 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: